Helius End Period Cash Flow from 2010 to 2025

HSDT Stock  USD 0.51  0  0.31%   
Helius Medical End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2025. From the period from 2010 to 2025, Helius Medical End Period Cash Flow quarterly data regression had r-value of  0.49 and coefficient of variation of  121.01. View All Fundamentals
 
End Period Cash Flow  
First Reported
2013-06-30
Previous Quarter
6.4 M
Current Value
3.5 M
Quarterly Volatility
5.5 M
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 280.8 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 8.29, Dividend Yield of 0.0 or PTB Ratio of 1.97. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Helius Medical Technologies over the last few years. It is Helius Medical's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Helius End Period Cash Flow Regression Statistics

Arithmetic Mean5,586,489
Geometric Mean533,621
Coefficient Of Variation121.01
Mean Deviation4,521,116
Median5,182,000
Standard Deviation6,760,132
Sample Variance45.7T
Range25.6M
R-Value0.49
Mean Square Error37.1T
R-Squared0.24
Significance0.05
Slope700,393
Total Sum of Squares685.5T

Helius End Period Cash Flow History

2025M
2024M
20235.2 M
202214.5 M
202111 M
20203.3 M
20195.5 M

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash FlowMM

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.